• JOIN
  • LOGIN
  • Deals
    • Private Equity
      • Investment
      • Fundraising
      • Exits
    • Venture Capital
      • Investment
      • Fundraising
      • Exits
    • Strategic Deals
    • DealShot
    • IPO
  • Tech
    • Aerospace
    • AI
    • Blockchain
    • Fintech
    • Internet
    • Smart Hardware
    • VR/AR
  • Industry
    • Consumer
    • Education
    • Entertainment
    • Healthcare
    • Mobility
    • Special Situations
  • Insights
    • Podcasts
    • China Money TV
    • China VC Tracker
    • Rankings
    • Events
    • Publications
    • Databank
  • 中文版
Search
            
  • Podcasts
  • Rankings
  • DealShot
  • Money TV
  • Events
  • Unicorns
         
  • LOGIN
  • JOIN
China Money Network China Money Network
China Money Network China Money Network
  • JOIN
  • LOGIN
  • Deals
    • Private Equity
      • Investment
      • Fundraising
      • Exits
    • Venture Capital
      • Investment
      • Fundraising
      • Exits
    • Strategic Deals
    • DealShot
    • IPO
  • Tech
    • Aerospace
    • AI
    • Blockchain
    • Fintech
    • Internet
    • Smart Hardware
    • VR/AR
  • Industry
    • Consumer
    • Education
    • Entertainment
    • Healthcare
    • Mobility
    • Special Situations
  • Insights
    • Podcasts
    • China Money TV
    • China VC Tracker
    • Rankings
    • Events
    • Publications
    • Databank
  • 中文版

Tag: biopharma

Fosun Teams Up With UK Healthcare Firm Arix Bioscience To Develop...

Yimian Wu - February 20, 2018 — 11:03

Lilly Asia Ventures Closes Fourth Fund At $450 Million Hard Cap

Pan Yue - August 15, 2017 — 11:04

Chinese Biopharma Firm CANbridge Life Sciences Raises $25M In Series B...

Jillian Yue - May 24, 2017 — 13:19

Oriza, YuanMing Lead $15.5M Round In Ascentage Pharma

Staff Writer - August 13, 2015 — 15:23

Follow on WeChat
Follow China Money Network on WeChat

Subscribe to Our Email Updates

.
.
.
.
.
.
.
.
.
.
  • Home
  • About Us
  • Contact Us
  • FAQs
  • Privacy
  • Terms & Conditions
  • LOGIN
  • JOIN
© 2019 China Money Network Limited. All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.